该项证书的获得标志着卓立汉光具备了国家及国际认可的管理水平和实验检测能力，有助于公司提升核 心竞争力、扩大行业影响力和品牌认知度，为公司高质量发展产生积极推动作用。 必创科技（300667）(300667.SZ)发布公告，公司全资子公司北京卓立汉光仪器有限公司(简称"卓立汉 光")于近日收到中国合格评定国家认可委员会("CNAS")授予的实验室认可证书。 ...

北京煜邦电力技术股份有限公司（以下简称"公司"）于近日通过中国合格评定国家认可委员会 （CNAS）的认可评定，获得其授予的实验室认可证书和认可决定书（以下简称"认可证书"），具体情 况如下： 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 一、基本情况 获得机构名称：北京煜邦电力技术股份有限公司实验中心 注册号：CNAS L24563 二、对公司的影响及风险提示 中国合格评定国家认可委员会（CNAS）是国际认可论坛（IAF）、国际实验室认可合作组织 （ILAC）、亚太实验室认可合作组织（APLAC）和太平洋认可合作组织（PAC）的正式成员。公司此 次获得认可证书，标志着公司检测中心的管理水平和检测能力获得国家及国际的认可，具备了按照国家 标准开展检测的能力，对保障公司产品质量强化公司产品研发能力、增强客户对公司的认同感及信任感 具有促进作用，有利于进一步提升公司的综合竞争力。 本次认可证书的获得不会对公司经营业绩产生重大影响，敬请广大投资者谨慎决策，注意投资风险。 三、备查文件 中国合格评定国家认可委员会实验室认可证书。 特 ...

人民财讯11月28日电，煜邦电力(688597)11月28日公告，公司于近日通过中国合格评定国家认可委员会 （CNAS）的认可评定，获得其授予的实验室认可证书和认可决定书。公司此次获得认可证书，标志着 公司检测中心的管理水平和检测能力获得国家及国际的认可，具备了按照国家标准开展检测的能力，对 保障公司产品质量强化公司产品研发能力、增强客户对公司的认同感及信任感具有促进作用，有利于进 一步提升公司的综合竞争力。 ...

格隆汇11月28日丨煜邦电力(688597.SH)公布，公司于近日通过中国合格评定国家认可委员会（CNAS） 的认可评定，获得其授予的实验室认可证书和认可决定书。 公司此次获得认可证书，标志着公司检测中心的管理水平和检测能力获得国家及国际的认可，具备了按 照国家标准开展检测的能力，对保障公司产品质量强化公司产品研发能力、增强客户对公司的认同感及 信任感具有促进作用，有利于进一步提升公司的综合竞争力。 ...

Core Viewpoint - The company has received a laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment (CNAS), which enhances its testing capabilities and credibility in the market [1][2]. Group 1: Basic Information - The accredited entity is the Yongzhen Green Energy Materials Research Institute (Changzhou) Co., Ltd. Testing Center [1]. - The registration number for the accreditation is CNAS L23913, effective from August 21, 2025, to August 20, 2031 [1]. - The certificate confirms compliance with ISO/IEC 17025:2017 standards, indicating the center's capability to perform the services listed in the certificate's annex [1]. Group 2: Impact on the Company - The CNAS accreditation signifies that the testing center's management and technical capabilities have been recognized at both national and international levels [2]. - This recognition is expected to enhance product quality assurance, strengthen product R&D capabilities, and increase customer trust and recognition of the company [2]. - The accreditation is anticipated to improve the company's overall competitiveness and support sustainable high-quality development [2].

Core Points - The company’s wholly-owned subsidiary, Yongzhen Green Energy Materials Research Institute (Changzhou) Co., Ltd., has received the laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment (CNAS) [1][2] - The accreditation certificate is valid from August 21, 2025, to August 20, 2031, and confirms that the testing center meets the requirements of ISO/IEC standards [1] - This recognition enhances the management level and technical capabilities of the testing center, promoting product quality assurance and strengthening product R&D capabilities [2] Company Impact - The CNAS accreditation signifies national and international recognition of the testing center's capabilities, which is expected to enhance customer trust and the company's overall competitiveness [2] - The laboratory accreditation is not anticipated to have a significant impact on the company's current operating performance [2]

Core Viewpoint - Yongzhen Co., Ltd. (603381.SH) announced that its wholly-owned subsidiary, Yongzhen Green Energy Materials Research Institute (Changzhou) Co., Ltd. has recently received a laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment (CNAS) [1] Group 1 - CNAS is recognized as an authoritative body for the evaluation of conformity assessment organizations, laboratories, inspection institutions, and verification bodies in China [1] - The accreditation by CNAS is based on the regulations of the "Certification and Accreditation Regulations of the People's Republic of China" and the "Supervision and Management Measures for Accreditation Institutions" [1] - CNAS plays a significant role in international recognition activities and is a member of the International Laboratory Accreditation Cooperation (ILAC) and the Asia-Pacific Accreditation Cooperation (APAC) mutual recognition agreements [1]

Core Viewpoint - Zhongjing Wanshi Pharmaceutical's testing center has received the CNAS laboratory accreditation, marking its entry into the international laboratory mutual recognition framework, which enhances the quality and credibility of traditional Chinese medicine [1][3]. Group 1: CNAS Accreditation - CNAS accreditation is one of the highest authorities in laboratory testing capabilities in China, aligning with international standards such as ISO/IEC 17025, providing international credibility to the company's testing data [3]. - The accreditation allows the company to achieve mutual recognition in over 100 countries and regions, enhancing its core competitiveness and global expansion opportunities [3]. Group 2: Testing Capabilities and Innovations - The testing center is equipped with advanced detection equipment, including ICP-MS, LC-MS, and GC-MS, focusing on precision, efficiency, and rigor to ensure drug quality and safety [3]. - The center has published six papers in national core journals and holds over ten patents, demonstrating its commitment to innovation and high-standard testing services [3]. Group 3: Quality Management and Standards - Zhongjing Wanshi Pharmaceutical emphasizes quality system construction and has participated in drafting quality standards for various traditional Chinese medicine products, establishing 19 industry standards and norms [5]. - The company has implemented a comprehensive quality control mechanism from seedling to consumer, continuously improving drug standardization management [5]. - The quality technology leader stated that CNAS recognition is both an affirmation of the existing system and a motivation for future improvements, aiming to provide higher quality and more reliable traditional Chinese medicine products [5].

Core Viewpoint - East Asia Pharmaceutical (605177) announced that its wholly-owned subsidiary, Hangzhou Shanli Biomedical Technology Co., Ltd., has recently obtained the laboratory accreditation certificate from the China National Accreditation Service for Conformity Assessment, which enhances the company's credibility and competitive edge in the market [1] Group 1 - The accreditation certificate is effective from May 20, 2025, to May 19, 2031, indicating a long-term recognition of the laboratory's management and technical capabilities [1] - This recognition allows Hangzhou Shanli's analysis laboratory to conduct testing according to national standards, thereby improving product quality and research capabilities [1] - The accreditation is expected to enhance customer trust and contribute to the company's high-quality development, although it will not have a significant impact on the company's current performance [1]

Core Viewpoint - The successful acquisition of the CNAS laboratory accreditation by the National Energy Investment Group Baiyin Hohhot Coal Industry Company signifies a major milestone in enhancing the company's quality management and testing capabilities, supporting its journey towards high-quality development [1][2]. Group 1: Laboratory Accreditation - The laboratory received the CNAS accreditation certificate, indicating that its quality management and testing capabilities meet national standards [1]. - The preparation for the CNAS certification involved systematic work, including the development of system documents, validation of testing methods, and personnel training [1]. - The evaluation by the expert group included a comprehensive assessment of the laboratory's management system, environmental facilities, testing processes, and quality control [1]. Group 2: Testing Capabilities - The expert group conducted on-site evaluations of seven key testing projects, including coal calorific value, carbon and hydrogen content, ash content, volatile matter, total moisture, and sulfur [1]. - The laboratory's technical capabilities, professional qualifications of personnel, and hardware facilities received high praise from the expert group [1]. Group 3: Future Directions - The company aims to leverage this accreditation as a new starting point to enhance technological innovation and improve testing accuracy [2]. - There is a commitment to continuously optimize management processes and introduce advanced testing technologies and methods [2]. - The company intends to deepen its expertise in coal quality testing and establish a more exemplary quality benchmark in the industry [2].